Parkinson disease and other neurodegenerative movement disorders: clinical and experimental research

News

Clínic Barcelona

Research July 20 2023

The Clinic-IDIBAPS receives an Edmond J. Safra Fellowship from the Michael J. Fox Foundation to train a neurologist specialised in movement disorders

The period for submitting applications for the fellowship, which will last two years, from 2024 to 2026, is now open. Francesc Valldeoriola, a neurol1

Clínic Barcelona

Research June 8 2023

Montse Cortijo, patient with Parkinson’s disease: “My arm was going numb and my hand was trembling. I could see that something was going on”

Montse Cortijo started to notice that her right arm was going numb, her hand was trembling and it was becoming increasingly difficult for her to do c1

Clínic Barcelona

Health Topics January 23 2023

Gene therapy: The future treatment for neurodegenerative diseases?

Gene therapy applied to the treatment of neurodegenerative diseases is a promising field of study, and consists of modifying a patient's genes to slo1

Clínic Barcelona

Research January 13 2023

Research provides new clues about iron toxicity in Parkinson's disease and explains the paradoxical effect of deferiprone

The results contrast with those of 4 previous independent clinical trials and could provide relevant information on the role of iron accumulation in1

Clínic Barcelona

Research July 20 2022

The combination of biomarkers in cerebrospinal fluid and magnetic resonance imaging enables differentiation between Parkinson’s disease and atypical parkinsonisms

The results of the study, led by Clínic-IDIBAPS researchers, could contribute to improving diagnosis of the disease.

2 3

page1
page2 , current page.
page3

News

The Clinic-IDIBAPS receives an Edmond J. Safra Fellowship from the Michael J. Fox Foundation to train a neurologist specialised in movement disorders

Montse Cortijo, patient with Parkinson’s disease: “My arm was going numb and my hand was trembling. I could see that something was going on”

Gene therapy: The future treatment for neurodegenerative diseases?

Research provides new clues about iron toxicity in Parkinson's disease and explains the paradoxical effect of deferiprone

The combination of biomarkers in cerebrospinal fluid and magnetic resonance imaging enables differentiation between Parkinson’s disease and atypical parkinsonisms

navigation between pages below